Ishii, M., Hirai, I., Tanese, K., Fusumae, T., Nakamura, Y., Fukuda, K., . . . Funakoshi, T. (2020). Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study). Medicine (Baltimore).
Dyfyniad Arddull ChicagoIshii, Maki, et al. "Anti-PD-1 Antibody Therapy for Epithelial Skin Malignancies: An Investigator-initiated, Open-label, Single-arm, Multicenter, Phase II Clinical Trial (NMSC-PD1 Study)." Medicine (Baltimore) 2020.
Dyfyniad MLAIshii, Maki, et al. "Anti-PD-1 Antibody Therapy for Epithelial Skin Malignancies: An Investigator-initiated, Open-label, Single-arm, Multicenter, Phase II Clinical Trial (NMSC-PD1 Study)." Medicine (Baltimore) 2020.